Rock Springs Capital Management as of March 31, 2023
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 121 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Humana (HUM) | 4.9 | $207M | 427k | 485.46 | |
Agilon Health (AGL) | 4.5 | $187M | 7.9M | 23.75 | |
Insulet Corporation (PODD) | 4.1 | $171M | 537k | 318.96 | |
Immunocore Hldgs Ads (IMCR) | 3.5 | $148M | 3.0M | 49.44 | |
Argenx Se Sponsored Adr (ARGX) | 3.1 | $130M | 350k | 372.58 | |
UnitedHealth (UNH) | 3.0 | $128M | 270k | 472.59 | |
Evolent Health Cl A (EVH) | 2.9 | $123M | 3.8M | 32.45 | |
Neurocrine Biosciences (NBIX) | 2.9 | $123M | 1.2M | 101.22 | |
Penumbra (PEN) | 2.9 | $121M | 434k | 278.69 | |
Prometheus Biosciences | 2.6 | $111M | 1.0M | 107.32 | |
IDEXX Laboratories (IDXX) | 2.5 | $104M | 208k | 500.08 | |
Blueprint Medicines (BPMC) | 2.2 | $92M | 2.0M | 44.99 | |
Karuna Therapeutics Ord | 2.1 | $90M | 494k | 181.64 | |
Madrigal Pharmaceuticals (MDGL) | 2.0 | $84M | 348k | 242.26 | |
Align Technology (ALGN) | 2.0 | $83M | 247k | 334.14 | |
Seagen | 1.9 | $81M | 400k | 202.47 | |
Horizon Therapeutics Pub L SHS | 1.9 | $81M | 740k | 109.14 | |
Intuitive Surgical Com New (ISRG) | 1.8 | $76M | 299k | 255.47 | |
West Pharmaceutical Services (WST) | 1.7 | $70M | 202k | 346.47 | |
Alnylam Pharmaceuticals (ALNY) | 1.6 | $69M | 345k | 200.32 | |
EXACT Sciences Corporation (EXAS) | 1.5 | $64M | 942k | 67.81 | |
Acadia Healthcare (ACHC) | 1.5 | $62M | 861k | 72.25 | |
Cerevel Therapeutics Hldng I (CERE) | 1.5 | $61M | 2.5M | 24.39 | |
Agios Pharmaceuticals (AGIO) | 1.5 | $61M | 2.7M | 22.97 | |
Sarepta Therapeutics (SRPT) | 1.5 | $61M | 443k | 137.83 | |
Dex (DXCM) | 1.4 | $57M | 491k | 116.18 | |
Akero Therapeutics (AKRO) | 1.3 | $56M | 1.5M | 38.26 | |
Ultragenyx Pharmaceutical (RARE) | 1.3 | $54M | 1.3M | 40.10 | |
Edwards Lifesciences (EW) | 1.3 | $53M | 646k | 82.73 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.1 | $46M | 426k | 107.22 | |
Freshpet (FRPT) | 1.0 | $44M | 663k | 66.19 | |
Mirum Pharmaceuticals (MIRM) | 1.0 | $43M | 1.8M | 24.02 | |
Amylyx Pharmaceuticals (AMLX) | 1.0 | $43M | 1.5M | 29.34 | |
Xenon Pharmaceuticals (XENE) | 1.0 | $42M | 1.2M | 35.79 | |
Pacira Pharmaceuticals (PCRX) | 1.0 | $42M | 1.0M | 40.81 | |
Phreesia (PHR) | 1.0 | $42M | 1.3M | 32.29 | |
Biomea Fusion (BMEA) | 1.0 | $40M | 1.3M | 31.01 | |
Mirati Therapeutics | 0.9 | $40M | 1.1M | 37.18 | |
Nevro (NVRO) | 0.9 | $39M | 1.1M | 36.15 | |
Irhythm Technologies (IRTC) | 0.9 | $38M | 310k | 124.03 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.9 | $37M | 1.7M | 22.53 | |
Accolade (ACCD) | 0.9 | $37M | 2.5M | 14.38 | |
Prothena Corp SHS (PRTA) | 0.9 | $37M | 754k | 48.47 | |
Kymera Therapeutics (KYMR) | 0.9 | $36M | 1.2M | 29.63 | |
Zai Lab Adr (ZLAB) | 0.8 | $35M | 1.1M | 33.26 | |
Aclaris Therapeutics (ACRS) | 0.8 | $32M | 4.0M | 8.09 | |
Abcam Ads | 0.7 | $30M | 2.2M | 13.46 | |
Travere Therapeutics (TVTX) | 0.7 | $29M | 1.3M | 22.49 | |
Rhythm Pharmaceuticals (RYTM) | 0.7 | $29M | 1.6M | 17.84 | |
Select Sector Spdr Tr Sbi Healthcare (XLV) | 0.6 | $26M | 200k | 129.46 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $26M | 265k | 97.24 | |
Shockwave Med | 0.6 | $25M | 115k | 216.83 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.5 | $22M | 458k | 48.22 | |
Lifestance Health Group (LFST) | 0.5 | $22M | 2.9M | 7.43 | |
CONMED Corporation (CNMD) | 0.5 | $21M | 205k | 103.86 | |
BioCryst Pharmaceuticals (BCRX) | 0.5 | $20M | 2.3M | 8.34 | |
Amryt Pharma Sponsored Ads | 0.5 | $19M | 1.3M | 14.58 | |
Brooks Automation (AZTA) | 0.5 | $19M | 431k | 44.62 | |
Inozyme Pharma (INZY) | 0.4 | $18M | 3.2M | 5.73 | |
Mineralys Therapeutics (MLYS) | 0.4 | $18M | 1.2M | 15.66 | |
Compass Therapeutics (CMPX) | 0.4 | $18M | 5.5M | 3.27 | |
Dynavax Technologies Corp Com New (DVAX) | 0.4 | $18M | 1.8M | 9.81 | |
Immatics SHS (IMTX) | 0.4 | $17M | 2.5M | 6.90 | |
Mersana Therapeutics (MRSN) | 0.4 | $17M | 4.1M | 4.11 | |
Cytokinetics Com New (CYTK) | 0.4 | $16M | 448k | 35.19 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $16M | 650k | 23.99 | |
Revolution Medicines (RVMD) | 0.4 | $15M | 703k | 21.66 | |
Celldex Therapeutics Com New (CLDX) | 0.4 | $15M | 422k | 35.98 | |
Warby Parker Cl A Com (WRBY) | 0.3 | $14M | 1.3M | 10.59 | |
Pliant Therapeutics (PLRX) | 0.3 | $13M | 491k | 26.60 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $13M | 577k | 21.76 | |
Amicus Therapeutics (FOLD) | 0.3 | $12M | 1.1M | 11.09 | |
Chinook Therapeutics | 0.3 | $12M | 508k | 23.15 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.3 | $11M | 1.0M | 11.07 | |
Relay Therapeutics (RLAY) | 0.3 | $11M | 674k | 16.47 | |
Health Catalyst (HCAT) | 0.3 | $11M | 930k | 11.67 | |
Aura Biosciences (AURA) | 0.2 | $9.5M | 1.0M | 9.28 | |
Biohaven (BHVN) | 0.2 | $9.4M | 686k | 13.66 | |
Verve Therapeutics (VERV) | 0.2 | $8.1M | 559k | 14.42 | |
Macrogenics (MGNX) | 0.2 | $8.1M | 1.1M | 7.17 | |
Novocure Ord Shs (NVCR) | 0.2 | $7.5M | 125k | 60.14 | |
Pulmonx Corp (LUNG) | 0.2 | $7.3M | 652k | 11.18 | |
Reneo Pharmaceuticals (RPHM) | 0.2 | $6.8M | 1.1M | 5.98 | |
Disc Medicine (IRON) | 0.2 | $6.6M | 314k | 21.19 | |
Spruce Biosciences (SPRB) | 0.1 | $6.0M | 2.7M | 2.21 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $5.3M | 480k | 10.96 | |
Icosavax | 0.1 | $5.0M | 865k | 5.80 | |
Guardant Health (GH) | 0.1 | $4.7M | 200k | 23.44 | |
Kinnate Biopharma | 0.1 | $4.7M | 747k | 6.25 | |
Vigil Neuroscience (VIGL) | 0.1 | $4.6M | 472k | 9.79 | |
Xilio Therapeutics (XLO) | 0.1 | $4.6M | 1.4M | 3.17 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $4.4M | 6.2M | 0.71 | |
Paratek Pharmaceuticals | 0.1 | $4.4M | 1.7M | 2.54 | |
Invitae (NVTAQ) | 0.1 | $4.4M | 3.2M | 1.35 | |
Theseus Pharmaceuticals | 0.1 | $3.9M | 437k | 8.88 | |
Novavax Com New (NVAX) | 0.1 | $3.7M | 535k | 6.93 | |
Fate Therapeutics (FATE) | 0.1 | $3.5M | 612k | 5.70 | |
Beam Therapeutics (BEAM) | 0.1 | $3.4M | 111k | 30.62 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $3.1M | 3.3M | 0.96 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $3.0M | 2.8M | 1.09 | |
Design Therapeutics (DSGN) | 0.1 | $2.7M | 460k | 5.77 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.1 | $2.6M | 9.6M | 0.28 | |
89bio Call Option (ETNB) | 0.1 | $2.5M | 165k | 15.23 | |
Fulcrum Therapeutics (FULC) | 0.0 | $2.1M | 728k | 2.85 | |
Tempest Therapeutics (TPST) | 0.0 | $1.9M | 824k | 2.32 | |
Gamida Cell SHS | 0.0 | $1.9M | 2.3M | 0.81 | |
Leap Therapeutics | 0.0 | $1.6M | 4.7M | 0.34 | |
Essa Pharma Com New (EPIX) | 0.0 | $1.6M | 525k | 2.97 | |
Nkarta (NKTX) | 0.0 | $1.4M | 393k | 3.55 | |
Gossamer Bio (GOSS) | 0.0 | $1.4M | 1.1M | 1.26 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.4M | 1.0M | 1.35 | |
Aeglea Biotherapeutics | 0.0 | $990k | 3.4M | 0.29 | |
Spero Therapeutics (SPRO) | 0.0 | $971k | 670k | 1.45 | |
Altimmune Com New (ALT) | 0.0 | $942k | 223k | 4.22 | |
Vincerx Pharma Com New (VINC) | 0.0 | $927k | 892k | 1.04 | |
Compugen Ord (CGEN) | 0.0 | $906k | 1.3M | 0.70 | |
Applied Therapeutics (APLT) | 0.0 | $633k | 781k | 0.81 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $470k | 500k | 0.94 | |
Atreca Cl A Com (BCEL) | 0.0 | $413k | 363k | 1.14 | |
Acelrx Pharmaceuticals Com New (TLPH) | 0.0 | $208k | 317k | 0.66 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $16k | 134k | 0.12 |